Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 2/20 | 0.33 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CPA1 | P15085 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28470194 | 0.72 | MEN1 (0.38) | ALDH1A1TSHR | |
| SCHEMBL4562097 | 0.72 | GRIK1 (0.36) | GRIK1GRIK2CYP2C19ALDH1A1TSHR | |
| SCHEMBL7600439 | 0.70 | GRIK1 (0.33) | GRIK1GRIK2CYP2C19ALDH1A1TSHR | |
| SCHEMBL15288867 | 0.70 | GRIK1 (0.33) | GRIK1GRIK2CYP2C19ALDH1A1TSHR | |
| SCHEMBL4682329 | 0.70 | GRIK1 (0.33) | GRIK1GRIK2CYP2C19ALDH1A1TSHR | |
| SCHEMBL8731754 | 0.69 | GRIK1 (0.37) | GRIK1GRIK2CYP2C19CPA1 | |
| SCHEMBL7596861 | 0.69 | GRIK1 (0.41) | GRIK1GRIK2CYP2C19CPA1 | |
| SCHEMBL3804586 | 0.69 | GRIK1 (0.32) | GRIK1GRIK2CYP2C19ALDH1A1TSHR | |
| SCHEMBL88777 | 0.69 | CYP2C19 (0.34) | GRIK1GRIK2CYP2C19ALDH1A1TSHR | |
| SCHEMBL7784551 | 0.69 | GRIK1 (0.32) | GRIK1GRIK2CYP2C19ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2399902-B1 | PROCESS FOR PREPARING 2,3-DI-NON-STRAIGHT-ALKYL-2-CYANO SUCCINIC ACID DIESTERS | CHINA PETROLEUM & CHEMICAL (CN) | 2014-11-26 | — | — | EP | disclosed |
| US-8669392-B2 | Process for preparing 2,3-di-non-straight-alkyl-2-cyanosuccinic acid diesters | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2014-03-11 | — | — | US | disclosed |
| US-8541333-B2 | Catalyst component for olefin polymerization and a catalyst comprising the same | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2013-09-24 | — | — | US | disclosed |
| EP-2287208-B1 | A catalyst component for olefin polymerization and a catalyst comprising the same | CHINA PETROLEUM & CHEMICAL (CN) | 2012-05-09 | — | — | EP | disclosed |
| US-20120046490-A1 | PROCESS FOR PREPARING 2,3-DI-NON-STRAIGHT-ALKYL-2-CYANOSUCCINIC ACID DIESTERS | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2012-02-23 | — | — | US | disclosed |
| EP-2399902-A1 | PROCESS FOR PREPARING 2,3-DI-NON-STRAIGHT-ALKYL-2-CYANO SUCCINIC ACID DIESTERS | China Petroleum & Chemical Corporation (CN) | 2011-12-28 | — | — | EP | disclosed |
| EP-2287208-A1 | A catalyst component for olefin polymerization and a catalyst comprising the same | China Petroleum & Chemical Corporation (CN) | 2011-02-23 | — | — | EP | disclosed |
| US-20110040051-A1 | CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND A CATALYST COMPRISING THE SAME | BEIJING RESEARCH INSTITUTE OF CHEMICAL INDUSTRY, CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2011-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046490-A1 | PROCESS FOR PREPARING 2,3-DI-NON-STRAIGHT-ALKYL-2-CYANOSUCCINIC ACID DIESTERS | ACMSD, ADSL, CNDP2 | GRIK1 703/4885GRIK2 209/4885CYP2C19 996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.